A cell-based quadrivalent flu vaccine will be available on the National Immunisation Program for the first time this year for patients at higher risk of complications from influenza.

From 1 March, Aboriginal and Torres Strait Islander people aged 5-64; pregnant women; and patients aged 5-64 with co-existing conditions, including diabetes, chronic renal failure, heart disease and chronic respiratory or neurological conditions, can get CSL Seqirus’ Flucelvax Quad for free.

Infectious diseases paediatrician Professor Robert Booy, from the University of Sydney, said the National Immunisation Program (NIP) listing gave GPs and patients “an important option for protection” given suboptimal uptake of the flu shot last year.

“In 2023, approximately 25% of the population aged 5-64 were vaccinated against influenza,” he said.